GemPharmatech
Joe Pottackal has extensive experience in finance and accounting roles. Joe currently holds the position of Director of Finance at GemPharmatech since June 2021. Prior to this, they worked as a Sr. Accounting and Finance Consultant at Aston Carter from June 2019 to June 2021, where they were responsible for various finance and accounting tasks such as financial analysis and reporting, building customized management financial reports, and preparing standard operating procedures. Joe also worked as a Consultant for Robert Half Management Resources from June 2018 to January 2019, focusing on general accounting and financial analysis. Before that, they served as a Senior Accountant Financial Reporting at Amtrak from May 2009 to December 2017. Joe's earlier experience includes working as a Consultant at Relevante, Inc. from February 2006 to October 2008, and as a Senior Accountant at American Water from February 2006 to February 2008.
Joe Pottackal completed a degree in IMED, specializing in Budgeting and Financial Management, at Rutgers University - Camden in 2009. Joe also holds a Master's degree in Accounting from the University of Kerala. No other information regarding their education history is provided.
This person is not in any teams
This person is not in any offices
GemPharmatech
1 followers
GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team has nearly 20 years of experience in gene-editing technology and animal production. GemPharmatech provides a one-stop service as model customization, breeding, phenotyping, and pharmacology for the biomedical research community. The company has developed the world's most abundant mouse strains resource to inspire scientific innovation and drive drug discovery.